[HTML][HTML] Inhaled aerosols: Their role in COVID-19 transmission, including biophysical interactions in the lungs

TR Sosnowski - Current Opinion in Colloid & Interface Science, 2021 - Elsevier
The high rate of spreading of COVID-19 is attributed to airborne particles exhaled by
infected but often asymptomatic individuals. In this review, the role of aerosols in SARS-CoV …

Dry powder inhalers in the digitalization era: current status and future perspectives

S Xiroudaki, A Schoubben, S Giovagnoli, DM Rekkas - Pharmaceutics, 2021 - mdpi.com
During the last decades, the term “drug delivery systems”(DDSs) has almost fully replaced
previously used terms, such as “dosage forms”, in an attempt to emphasize the importance …

Particle size dynamics: toward a better understanding of electronic cigarette aerosol interactions with the respiratory system

TR Sosnowski, M Odziomek - Frontiers in physiology, 2018 - frontiersin.org
The knowledge of possible acute and long-term health effects of aerosols inhaled from
electronic cigarettes (ECs) is still limited partially due to incomplete awareness of physical …

A particle technology approach toward designing dry-powder inhaler formulations for personalized medicine in respiratory diseases

K Kadota, TR Sosnowski, S Tobita, I Tachibana… - Advanced Powder …, 2020 - Elsevier
Compared with oral and parenteral formulations, inhaled formulations are attractive because
of their great benefit and potential to enhance therapeutic effects of medications. Among the …

Preclinical development of orally inhaled drugs (OIDs)—are animal models predictive or shall we move towards in vitro non-animal models?

D Movia, A Prina-Mello - Animals, 2020 - mdpi.com
Simple Summary This commentary focuses on the methods currently available to test the
efficacy and safety of new orally inhaled drugs for the treatment of uncurable respiratory …

Advances in audio-based systems to monitor patient adherence and inhaler drug delivery

TE Taylor, Y Zigel, C De Looze, I Sulaiman… - Chest, 2018 - Elsevier
Hundreds of millions of people worldwide have asthma and COPD. Current medications to
control these chronic respiratory diseases can be administered using inhaler devices, such …

Nebulizer systems: a new frontier for therapeutics and targeted delivery

SV Khairnar, DD Jain, SM Tambe, YR Chavan… - Therapeutic …, 2022 - Taylor & Francis
Drug delivery via the pulmonary route is a cornerstone in the pharmaceutical sector as an
alternative to oral and parenteral administration. Nebulizer inhalation treatment offers …

Aqueous dispersions of oxygen nanobubbles for potential application in inhalation therapy

M Odziomek, K Ulatowski, K Dobrowolska, I Górniak… - Scientific Reports, 2022 - nature.com
Inhalation is a non-invasive method of local drug delivery to the respiratory system. This
study analyzed the potential use of aqueous dispersion of oxygen nanobubbles (ADON) as …

A path forward in the development of new aerosol drug delivery devices for pediatrics

JA O'Neil, LA Villasmil-Urdaneta - Respiratory Medicine, 2023 - Elsevier
Inhaled medications are widely accepted as being the optimal route for treating pediatric
respiratory diseases, a leading cause of hospitalization and death. Despite jet nebulizers …

Results of a patient survey regarding COPD knowledge, treatment experiences, and practices with inhalation devices

R Dhand, DA Mahler, BW Carlin, NA Hanania… - Respiratory …, 2018 - rc.rcjournal.com
BACKGROUND: Successful inhalation therapy depends on the ability of patients with COPD
to properly use devices. We explored subjects' COPD knowledge, including education they …